Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay),indirectly disrupting citrate binding via an unexpected mechanism of inhibition.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | In stock | $ 40.00 | |
5 mg | In stock | $ 61.00 | |
10 mg | In stock | $ 101.00 | |
25 mg | In stock | $ 207.00 | |
50 mg | In stock | $ 369.00 | |
100 mg | In stock | $ 394.00 |
Description | NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay),indirectly disrupting citrate binding via an unexpected mechanism of inhibition. |
Targets&IC50 | human ATP-citrate lyase:2.1 nM |
Molecular Weight | 453.84 |
Formula | C20H14ClF2NO5S |
CAS No. | 2375840-87-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 91 mg/mL (200.51 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NDI-091143 2375840-87-0 Metabolism ATP Citrate Lyase ACLY inhibit NDI091143 NDI 091143 Inhibitor inhibitor